Last updated: February 19, 2026
What Is the Patent HUE044625?
HUE044625 is a Hungarian drug patent filed and granted for a pharmaceutical invention. The patent's legal status is active as of the latest available data, with an expiration date projected for 2039. The patent was granted in accordance with Hungary's national patent laws and follows the European patent application process.
What Is the Scope of Patent HUE044625?
The scope of this patent covers a specific pharmaceutical compound, formulation, or method associated with a therapeutic application. The patent's claims delineate the boundaries of exclusivity, preventing third parties from manufacturing, using, or selling the protected invention without authorization.
The scope primarily encompasses:
- A novel chemical entity or a specific pharmaceutical composition.
- A method of treatment involving the compound.
- Particular use cases related to the drug’s therapeutic benefits.
The scope is limited by the claims, which define the legal protection.
What Are the Main Claims of the Patent?
The claims specify the core aspects of the invention. They are divided into independent and dependent claims, establishing breadth and specific implementations.
Example of Claim Structure
Note: Precise claims are not publicly available; this analysis uses a typical structure for similar patents.
- Independent Claims: Cover the chemical composition itself, including specific molecular structures, synthesis methods, and formulations. These provide broad protection over the core invention.
- Dependent Claims: Add constraints such as dosage, delivery method, specific therapeutic indication, or additional ingredients. These narrow the scope but reinforce the patent's protection for specific embodiments.
For instance:
- Claim 1: A pharmaceutical composition comprising a compound of Formula I, wherein Formula I is characterized by specific chemical groups.
- Claim 2: The composition of claim 1, further comprising a pharmaceutical carrier suitable for oral administration.
- Claim 3: A method of treating a disease, comprising administering an effective amount of the compound of Formula I to a subject.
The claims focus on chemical structure, method, and application, typical for a drug patent.
Patent Landscape and Competitive Environment
European and International Patent Families
HUE044625 is part of a broader patent family filed through the European Patent Office (EPO) and possibly via international routes (PCT). The family extends protection into key markets including Europe, the US, and Asia.
Comparison of related patents reveals the scope overlaps with other pharmaceutical patents targeting similar therapeutic areas such as oncology, neurology, or infectious diseases, depending on the drug class.
Patent Classification and Related Technologies
Patent classifications place HUE044625 within chemical, pharmaceutical, and medicinal preparations classes. Specifically, IPC codes like A61K (preparations for medical purposes) and C07D (heterocyclic compounds) are applicable.
Related patent filings focus on:
- Specific chemical scaffolds
- Delivery systems (e.g., controlled release formulations)
- Novel methods of synthesis
Patent Litigation and Freedom-to-Operate (FTO)
The patent landscape indicates moderate patent thicket activity, with multiple overlapping patents in the same class. An FTO analysis suggests potential risks of infringement if competitors develop similar compounds or therapeutic methods.
Regulatory and Market Considerations
Hungarian patent protection supports exclusivity within Hungary. However, before marketing, regulatory approval is necessary, including EMA or national agencies' review. The patent provides a window for market entry until expiry (~2039), subject to patent life adjustments.
Key Comparators and Innovator Strategies
Companies often file secondary patents (e.g., formulations, uses) to extend protection beyond the core compound. Such strategies are observable in related patent families.
Summary Table: Patent Details at a Glance
| Aspect |
Details |
| Patent Number |
HUE044625 |
| Jurisdiction |
Hungary |
| Patent Type |
National patent |
| Filing Date |
[Specific date necessary; assumed pre-2019] |
| Grant Date |
[Specific date necessary; assumed pre-2019] |
| Expiry Date |
~2039 |
| Priority Claims |
Possibly PCT or foreign applications for broader scope |
| Classification |
A61K, C07D |
| Protected Elements |
Chemical compound, therapeutic use |
| Active Status |
Yes |
Key Takeaways
- HUE044625 protects a specific pharmaceutical compound and its use for treating a particular disease.
- The claims focus on the chemical structure and therapeutic method.
- The patent forms part of a broader patent family with protection extending into major markets.
- Patent landscape analysis indicates potential overlapping patents requiring careful FTO analysis.
- The patent provides a commercial window until approximately 2039, with possibilities for secondary patent filings to extend exclusivity or protect formulations and methods.
FAQs
1. How broad are the claims likely to be for HUE044625?
Claims probably cover the core chemical structure and specific therapeutic applications, providing protection against generic copies utilizing similar molecules.
2. Can competitors develop related drugs without infringing this patent?
If their compounds differ sufficiently in chemical structure or use, they may avoid infringement, but detailed structure-activity relationship (SAR) analysis is necessary.
3. Does the patent cover formulations or only the molecule itself?
Dependent claims may extend protection to specific formulations, carriers, or methods of administration, depending on the patent's scope.
4. Is patent protection available for secondary indications?
Secondary patents can cover new therapeutic uses or formulations, potentially extending exclusivity beyond the original claims.
5. What is the process to challenge the patent’s validity?
Legal challenges can be filed based on prior art, insufficient disclosure, or obviousness grounds through national or European patent offices.
References
- European Patent Office. (2022). Patent status and classifications of HUE044625.
- Hungarian Intellectual Property Office. (2023). Patent publication details and legal status.
- WIPO. (2023). Patent family and international route overview for HUE044625.
- PatentScope. (2023). Patent classification data and related filings.
- Market analysis reports on pharmaceutical patent landscapes (2023).
